Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise:

Digital Health

Job title: Chief Innovation Officer
Dr Ami B Bhatt, MD, FACC, is the CIO at the American College of Cardiology (ACC), previously Director of Outpatient and TeleCardiology at Massachusetts General Hospital and an Associate Professor at Harvard Medical School. With 20 years of experience, she focuses on digital health strategy and transforming cardiovascular care. She founded a cardiovascular virtual care program in 2013 and… View more
Author(s): Joe Gallagher , Chris Watson , Patricia Campbell , et al Added: 3 years ago
Increasingly biomarkers are of interest in cardiovascular disease (CVD) for risk stratification. In particular, natriuretic peptides (NPs), which were originally used for the diagnosis of heart failure, are now finding a role in identifying those most at risk of heart failure and other cardiovascular (CV) disorders. Their ability to be measured rapidly through blood tests makes their widespread… View more
Author(s): Yugo Yamashita Added: 8 months ago
What's hot at the European Society of Cardiology (ESC) Congress 2023? Browse our curated coverage of the latest updates in cardiology from Amsterdam. Watch ourView From the Thoraxcenterseries for a concise line up of the most awaited trials fromProf Nicolas Van MieghemandDr Joost Daemen. For a deeper dive into key clinical trial data and its applicability, host,Dr Harriette Van… View more
Research Area(s) / Expertise:

Intervention

Dr Ankur Kalra is an interventional cardiologist, and founder of the non-profit startup,makeadent.org. He is primary investigator at Krannert Cardiovascular Research Center, and an adjunct clinical associate professor of cardiology at Indiana University School of Medicine. He is director of Barry J Maron Hypertrophic Cardiomyopathy Center in New Delhi, India. He is also the host of the award… View more
Author(s): Ami Bhatt Added: 1 week ago
ACC 2024 — Dr Ami B Bhatt, Chief Innovation Officer of ACC, joins us to highlight key information regarding artificial intelligence innovations in cardiology in 2024.Dr Bhatt discusses the potential progress and innovation that artificial intelligence can provide in clinical medicine, including risk predictions, artificial intelligence use in EKGs, large language models and virtual learning… View more
Author(s): Domenico D’Amario , Francesco Canonico , Daniele Rodolico , et al Added: 3 years ago
Heart failure (HF) is a complex clinical syndrome associated with a heavy burden of symptoms and a wide range of therapeutic options.1–5 Despite improvements in HF management over past decades, we still need approaches that might mitigate the effects of this disease, preventing its insidious onset and worsening of symptoms, such as acute decompensations. A trend has recently emerged to extend the… View more
Author(s): Patrik Bachtiger , Carla M Plymen , Punam A Pabari , et al Added: 3 years ago
Although cardiovascular disease is the leading cause of death globally, an increasing proportion of patients are surviving with heart failure (HF), which is substantially increasing in incidence and prevalence.1,2 In the management of HF the indications for implanted devices have widened, resulting in more patients living with an expanding variety of sensor-enabled implanted devices than any… View more
Author(s): Mikhail Kosiborod , Shelley Zieroth , Andrew JS Coats , et al Added: 1 year ago
This series of peer-to-peer discussions examines the practicalities of personalising heart failure management in the context of recent changes to international clinical practice guidelines. At this exciting juncture, we now have two SGLT-2 inhibitors that offer clinical benefit across the spectrum of ejection fraction, and an increasing body of real-world and registry-based data showing… View more
Author(s): Fang Fang , Zhou Yu Jie , Luo Xiu Xia , et al Added: 3 years ago
The prevalence of heart failure (HF) is still high1 and is rising in developing countries.2 Despite optimal medical therapy, refractory HF is a common occurrence and remains a “global disease requiring global response.”3 The emergence of cardiac resynchronisation therapy (CRT), has brought a new paradigm in the management of HF. CRT has been the most promising device therapy in mild-to-severe HF… View more